Functional diversity of mammalian type 2C protein phosphatase isoforms: New tales from an old family

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 2, 2008, Pages 107-112

  Lu, Gang ^a   Wang, Yibin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human disease; Protein phosphatase; Signal transduction; Type 2C protein phosphatase (PP2C) isoforms

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PP 2 C; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HUMAN; MAMMAL; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; SHORT SURVEY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL CYCLE; CELL DEATH; DNA DAMAGE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 38149011286     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04843.x     Document Type: Short Survey

References (56)

1. Caenepeel S, Charydczak G, Sudarsanam S, Hunter T, Manning G. The mouse kinome: Discovery and comparative genomics of all mouse protein kinases. Proc. Natl Acad. Sci. USA 2004 101: 11 707 12.
2. Cohen PCT. Overview of protein serine/threonine phosphatases. In: Arino J, Alexander DR (eds). Topics in Current Genetics, Vol. 5. Springer, Heidelberg. 2004 1 20.
3. Cohen PTW. Nomenclature and chromosomal localization of human protein serine/threonine phosphatase genes. Adv. Protein Phosphatases 1994 8: 371 6.
4. Stern A, Privman E, Rasis M, Lavi S, Pupko T. Evolution of the metazoan protein phosphatase 2C superfamily. J. Mol. Evol. 2007 64: 61 70.
5. Lu G, Ren S, Korge P et al. A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development. Genes Dev. 2007 21: 784 96.
6. Posas F, Takekawa M, Saito H. Signal transduction by MAP kinase cascades in budding yeast. Curr. Opin. Microbiol. 1998 1: 175 82.
7. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 2007 26: 3100 12.
8. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J. Biol. Chem. 1995 270: 14 843 6.
9. Takekawa M, Maeda T, Saito H. Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J. 1998 17: 4744 52.
10. Hanada M, Kobayashi T, Ohnishi M et al. Selective suppression of stress-activated protein kinase pathway by protein phosphatase 2C in mammalian cells. FEBS Lett. 1998 437: 172 6.
11. Hanada M, Ninomiya-Tsuji J, Komaki K et al. Regulation of the TAK1 signaling pathway by protein phosphatase 2C. J. Biol. Chem. 2001 276: 5753 9.
12. Saito JI, Toriumi S, Awano K et al. Regulation of apoptosis signal-regulating kinase 1 by protein phosphatase 2Cepsilon. Biochem. J. 2007 405: 591 6.
13. Li MG, Katsura K, Nomiyama H et al. Regulation of the interleukin-1-induced signaling pathways by a novel member of the protein phosphatase 2C family (PP2Cepsilon). J. Biol. Chem. 2003 278: 12 013 21.
14. Vahebi S, Ota A, Li M et al. p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity. Circ. Res. 2007 100: 408 15.
15. Liu HH, Xie M, Schneider MD, Chen ZJ. Essential role of TAK1 in thymocyte development and activation. Proc. Natl Acad. Sci. USA 2006 103: 11 677 82.
16. Matsukawa J, Matsuzawa A, Takeda K, Ichijo H. The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. 2004 136: 261 5.
17. Tamura S, Toriumi S, Saito J, Awano K, Kudo TA, Kobayashi T. PP2C family members play key roles in regulation of cell survival and apoptosis. Cancer Sci. 2006 97: 563 7.
18. Hawkins PT, Anderson KE, Davidson K, Stephens LR. Signalling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 2006 34: 647 62.
19. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: A hard Akt to follow. Trends Biochem. Sci. 2001 26: 657 64.
20. Mendoza MC, Blenis J. PHLPPing it off: Phosphatases get in the Akt. Mol. Cell 2007 25: 798 800.
21. Foukas LC, Beeton CA, Jensen J, Phillips WA, Shepherd PR. Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo. Mol. Cell. Biol. 2004 24: 966 75.
22. Dhand R, Hiles I, Panayotou G et al. PI 3-kinase is a dual specificity enzyme: Autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 1994 13: 522 33.
23. Yoshizaki T, Maegawa H, Egawa K et al. Protein phosphatase-2C alpha as a positive regulator of insulin sensitivity through direct activation of phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J. Biol. Chem. 2004 279: 22 715 26.
24. Bellacosa A, Testa JR, Moore R, Larue L. A portrait of AKT kinases: Human cancer and animal models depict a family with strong individualities. Cancer Biol. Ther. 2004 3: 268 75.
25. Brognard J, Sierecki E, Gao T, Newton AC. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 2007 25: 917 31.
26. Gao T, Furnari F, Newton AC. PHLPP. A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 2005 18: 13 24.
27. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006 441: 523 7.
28. Stambolic V, Woodgett JR. Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration. Trends Cell Biol. 2006 16: 461 6.
29. Jacinto E, Facchinetti V, Liu D et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006 127: 125 37.
30. Yang Q, Inoki K, Ikenoue T, Guan KL. Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 2006 20: 2820 32.
31. Shimizu K, Okada M, Nagai K, Fukada Y. Suprachiasmatic nucleus circadian oscillatory protein, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway. J. Biol. Chem. 2003 278: 14 920 5.
32. Okkenhaug K, Vanhaesebroeck B. New responsibilities for the PI3K regulatory subunit p85 alpha. Sci. STKE 2001 2001: PE1.
33. Harrison JC, Haber JE. Surviving the breakup: The DNA damage checkpoint. Annu. Rev. Genet. 2006 40: 209 35.
34. Motoyama N, Naka K. DNA damage tumor suppressor genes and genomic instability. Curr. Opin. Genet. Dev. 2004 14: 11 16.
35. Leroy C, Lee SE, Vaze MB et al. PP2C phosphatases Ptc2 and Ptc3 are required for DNA checkpoint inactivation after a double-strand break. Mol. Cell 2003 11: 827 35.
36. Shreeram S, Demidov ON, Hee WK et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol. Cell 2006 23: 757 64.
37. Lu X, Nannenga B, Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 2005 19: 1162 74.
38. Fujimoto H, Onishi N, Kato N et al. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ. 2006 13: 1170 80.
39. Oliva-Trastoy M, Berthonaud V, Chevalier A et al. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase. Oncogene 2007 26: 1449 58.
40. Takekawa M, Adachi M, Nakahata A et al. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 2000 19: 6517 26.
41. Lu X, Bocangel D, Nannenga B, Yamaguchi H, Appella E, Donehower LA. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol. Cell 2004 15: 621 34.
42. Fiscella M, Zhang H, Fan S et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl Acad. Sci. USA 1997 94: 6048 53.
43. Bulavin DV, Demidov ON, Saito S et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 2002 31: 210 15.
44. Li J, Yang Y, Peng Y et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat. Genet. 2002 31: 133 4.
45. Bulavin DV, Phillips C, Nannenga B et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16 (Ink4a)-p19 (Arf) pathway. Nat. Genet. 2004 36: 343 50.
46. Harrison M, Li J, Degenhardt Y, Hoey T, Powers S. Wip1-deficient mice are resistant to common cancer genes. Trends Mol. Med. 2004 10: 359 61.
47. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 2000 10: 886 95.
48. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998 273: 5858 68.
49. Fernandez-Capetillo O, Allis CD, Nussenzweig A. Phosphorylation of histone H2B at DNA double-strand breaks. J. Exp. Med. 2004 199: 1671 7.
50. Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol. Cell 2005 20: 801 9.
51. Murray MV, Kobayashi R, Krainer AR. The type 2C Ser/Thr phosphatase PP2Cgamma is a pre-mRNA splicing factor. Genes Dev 1999 13: 87 97.
52. Kimura H, Takizawa N, Allemand E et al. A novel histone exchange factor, protein phosphatase 2Cgamma, mediates the exchange and dephosphorylation of H2A-H2B. J. Cell Biol. 2006 175: 389 400.
53. Horbinski C, Chu CT. Kinase signaling cascades in the mitochondrion: A matter of life or death. Free Radic. Biol. Med. 2005 38: 2 11.
54. Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother. Pharmacol. 2006 57: 545 53.
55. Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/reperfusion injury. Ann. N.Y. Acad. Sci. 2005 1047: 248 58.
56. Klumpp S, Thissen MC, Krieglstein J. Protein phosphatases types 2Calpha and 2Cbeta in apoptosis. Biochem. Soc. Trans. 2006 34: 1370 5.